Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-29

Study Completion Date

2018-09-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this pilot study is to analyze the differences in time to first postoperative neurological examination (cranial nerve XII - tongue movement, movement of extremities) and intraoperative hemodynamic stability with three different general anesthetic techniques that are used for carotid endarterectomy. Carotid endarterectomy surgery removes the plaque and stenosis but has a 1-3% risk of periprocedural stroke or death. The ability to detect neurological abnormalities early after surgery is vital in this patient population to facilitate timely additional diagnostics or interventions if a potential stroke is detected. Anesthetic techniques that facilitate an earlier reliable neurological exam will thus greatly benefit this surgical patient population. The primary objective of this pilot study is to determine the time difference from end of surgery to first neurologic exam between three commonly used anesthetic methods for carotid endareterectomy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Brain Damage Resulting From Carotid Endarterectomy With Xenon Anesthesia

NCT01404819

Carotid Endarterectomy

COMPLETED NA

The Effects of Anaesthesia on Cerebral Oxygenation and Cognitive Function in Carotid Endarterectomy

NCT02771418

Endarterectomy Postoperative Cognitive Dysfunction

COMPLETED NA

Effect of Regional Versus General Anesthesia on Thirty-day Outcomes Following Carotid Endarterectomy: a Matched-pairs Cohort Study.

NCT05706688

Regional Anesthesia Morbidity Carotid Artery Diseases Perioperative/Postoperative Complications

COMPLETED

Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia for Long Duration Neurosurgery

NCT01985854

Patients Undergoing Elective Craniotomy

UNKNOWN PHASE4

Effect of Sedation Strategy on Duration Mechanical Ventilation in Patient After Cardiac Surgery

NCT05451121

Respiratory Failure Mechanical Ventilation Complication Sedation Complication

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Carotid endarterectomy reduces the incidence of stroke in people with symptomatic, severe carotid artery stenosis. However, there are risks associated with this procedure such as stroke from carotid clamping with poor collateral brain circulation or embolization of carotid plaque debris (Sheth, 2017). Few surgeons monitor the brain during the procedure using SSEP or EEG, as most rely on intraoperative blood pressure management, shunting, and postoperative neurological exam (De Santis, 2016; Kobayashi, 2011).

A Cochrane review of regional versus general anesthesia for carotid endarterectomy reveals no significant difference in outcomes (Vaniyaping, 2013). It is common practice at Cooper Hospital to deliver general anesthesia. The general anesthetic given may affect the length of time to first post-operative neurological response and the hemodynamic stability, though this is not well studied.

A search in PubMed in April 2017 for "carotid endarterectomy AND (general anesthesia OR total intravenous anesthesia OR regional anesthesia) AND neurologic exam" ("endarterectomy, carotid"\[MeSH Terms\] OR ("endarterectomy"\[All Fields\] AND "carotid"\[All Fields\]) OR "carotid endarterectomy"\[All Fields\] OR ("carotid"\[All Fields\] AND "endarterectomy"\[All Fields\])) AND (("general anaesthesia"\[All Fields\] OR "anesthesia, general"\[MeSH Terms\] OR ("anesthesia"\[All Fields\] AND "general"\[All Fields\]) OR "general anesthesia"\[All Fields\] OR ("general"\[All Fields\] AND "anesthesia"\[All Fields\])) OR (total\[All Fields\] AND ("intravenous anaesthesia"\[All Fields\] OR "anesthesia, intravenous"\[MeSH Terms\] OR ("anesthesia"\[All Fields\] AND "intravenous"\[All Fields\]) OR "intravenous anesthesia"\[All Fields\] OR ("intravenous"\[All Fields\] AND "anesthesia"\[All Fields\]))) OR ("regional anaesthesia"\[All Fields\] OR "anesthesia, conduction"\[MeSH Terms\] OR ("anesthesia"\[All Fields\] AND "conduction"\[All Fields\]) OR "conduction anesthesia"\[All Fields\] OR ("regional"\[All Fields\] AND "anesthesia"\[All Fields\]) OR "regional anesthesia"\[All Fields\])) AND (neurologic\[All Fields\] AND exam\[All Fields\]) revealed no studies comparing anesthetic types and time to first post-operative neurological response in this surgical population. Through anecdotal experience at Cooper Hospital, patients are noted to emerge faster and follow commands sooner when not given preoperative midazolam and given a combined Total Intravenous Anesthetic (TIVA) and volatile inhalational anesthetic technique titrated to a bispectral index (BIS) of 50-60.

Ruling out anesthetic causes of abnormal neurological function is vital in this patient population. Neurological dysfunction that is surgical in nature may require early intervention such as surgical reexploration or CT scan. "Time is brain", and a few minutes difference is enough to cause permanent neurological damage if a progressing stroke is not quickly identified. Anesthetic techniques that demonstrate a quicker return to baseline neurological function will greatly benefit this surgical patient population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carotid Artery Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Remifentanil, Propofol, and Desflurane

Study group A: no midazolam given; maintenance drugs started immediately after induction and airway is secured.

Group Type ACTIVE_COMPARATOR

Remifentanil, Propofol, and Desflurane

Intervention Type DRUG

Remifentanil - titratable; initial starting dose 0.05 mcg/kg/min Propofol - titratable; initial starting dose 75 mcg/kg/min Desflurane 0.5 MAC

Remifentanil, Dexmedetomidine, and Desflurane

Study group B: no midazolam given; maintenance drugs started immediately after induction and airway is secured.

Group Type ACTIVE_COMPARATOR

Remifentanil, Dexmedetomidine, and Desflurane

Intervention Type DRUG

Remifentanil - titratable; initial starting dose 0.05 mcg/kg/min Dexmedetomidine - titratable; initial starting dose 0.5 mcg/kg/hr Desflurane 0.5 MAC

Remifentanil and Desflurane

Study group C (control group): no midazolam given; maintenance drugs started immediately after induction and airway is secured.

Group Type ACTIVE_COMPARATOR

Remifentanil and Desflurane

Intervention Type DRUG

Remifentanil - titratable; initial starting dose 0.05 mcg/kg/min Desflurane - titratable

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remifentanil, Propofol, and Desflurane

Remifentanil - titratable; initial starting dose 0.05 mcg/kg/min Propofol - titratable; initial starting dose 75 mcg/kg/min Desflurane 0.5 MAC

Intervention Type DRUG

Remifentanil, Dexmedetomidine, and Desflurane

Remifentanil - titratable; initial starting dose 0.05 mcg/kg/min Dexmedetomidine - titratable; initial starting dose 0.5 mcg/kg/hr Desflurane 0.5 MAC

Intervention Type DRUG

Remifentanil and Desflurane

Remifentanil - titratable; initial starting dose 0.05 mcg/kg/min Desflurane - titratable

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ultiva Diprivan Suprane Ultiva Suprane Precedex Ultiva Suprane

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 18 years of age and older
2. Having carotid endarterectomy surgery
3. Able to undergo a preoperative neurological exam

Exclusion Criteria

1. Pregnant patients
2. Prisoners
3. Patients with dementia or reduced mental status acute or chronic
4. Known brain tumor or head trauma
5. Known severe, uncorrected coronary artery disease (CAD)
6. Ejection fraction (EF) less than 15%
7. Patients with intraaortic ballon pump (IABP) or other mechanical circulatory assist device
8. Patients with severe chronic obstructive pulmonary disease (COPD)
9. Combined surgical procedures (CABG and CAD)
10. Patients with uncontrolled or severe anxiety requiring benzodiazepine administration
11. Patients with history of difficult airway
12. Sedation other than propofol, dexmedetomidine or volatile anesthetic agent (VAA) is needed for patient (i.e. ketamine in patients with history of neuropathic pain)
13. Intubated or unconscious patients
14. Patients on methadone or fentanyl patch
15. Patients with known unusual or extreme anesthetic requirements
16. Patients who would require an unusual amount of narcotic to control pain
17. Patients having endarterectomy wherein surgeon requests local-regional anesthesia only
18. Patients with known history of prolonged emergence from anesthesia
19. Morbidly obese patients (BMI \>40)
20. Patients with scalp or forehead defects that prohibit application of BIS monitor strip

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No